Sheppard DN - Search Results

1

Fluorinated synthetic anion carriers: experimental and computational insights into transmembrane chloride transport.

Spooner MJ, Li H, Marques I, Costa PMR, Wu X, Howe ENW, Busschaert N, Moore SJ, Light ME, Sheppard DN, Félix V, Gale PA. Spooner MJ, et al. Among authors: sheppard dn. Chem Sci. 2018 Dec 14;10(7):1976-1985. doi: 10.1039/c8sc05155k. eCollection 2019 Feb 21. Chem Sci. 2018. PMID: 30881627 Free PMC article.

2

Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by niflumic acid.

Scott-Ward TS, Li H, Schmidt A, Cai Z, Sheppard DN. Scott-Ward TS, et al. Among authors: sheppard dn. Mol Membr Biol. 2004 Jan-Feb;21(1):27-38. doi: 10.1080/09687680310001597758. Mol Membr Biol. 2004. PMID: 14668136 Free article.

3

Transepithelial electrical measurements with the Ussing chamber.

Li H, Sheppard DN, Hug MJ. Li H, et al. Among authors: sheppard dn. J Cyst Fibros. 2004 Aug;3 Suppl 2:123-6. doi: 10.1016/j.jcf.2004.05.026. J Cyst Fibros. 2004. PMID: 15463943 Free article. Review.

4

Strategies to investigate the mechanism of action of CFTR modulators.

Cai Z, Scott-Ward TS, Li H, Schmidt A, Sheppard DN. Cai Z, et al. Among authors: sheppard dn. J Cyst Fibros. 2004 Aug;3 Suppl 2:141-7. doi: 10.1016/j.jcf.2004.05.030. J Cyst Fibros. 2004. PMID: 15463947 Free article. Review.

5

The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.

Li H, Findlay IA, Sheppard DN. Li H, et al. Among authors: sheppard dn. Kidney Int. 2004 Nov;66(5):1926-38. doi: 10.1111/j.1523-1755.2004.00967.x. Kidney Int. 2004. PMID: 15496164 Free article.

6

The cystic fibrosis transmembrane conductance regulator Cl⁻ channel: a versatile engine for transepithelial ion transport.

Li H, Cai Z, Chen JH, Ju M, Xu Z, Sheppard DN. Li H, et al. Among authors: sheppard dn. Sheng Li Xue Bao. 2007 Aug 25;59(4):416-30. Sheng Li Xue Bao. 2007. PMID: 17700962 Free article.

7

Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease.

Li H, Sheppard DN. Li H, et al. Among authors: sheppard dn. BioDrugs. 2009;23(4):203-16. doi: 10.2165/11313570-000000000-00000. BioDrugs. 2009. PMID: 19697963 Review.

8

Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis.

Cai ZW, Liu J, Li HY, Sheppard DN. Cai ZW, et al. Among authors: sheppard dn. Acta Pharmacol Sin. 2011 Jun;32(6):693-701. doi: 10.1038/aps.2011.71. Acta Pharmacol Sin. 2011. PMID: 21642944 Free PMC article. Review.

9

Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth.

Li H, Yang W, Mendes F, Amaral MD, Sheppard DN. Li H, et al. Among authors: sheppard dn. Am J Physiol Renal Physiol. 2012 Oct 15;303(8):F1176-86. doi: 10.1152/ajprenal.00130.2012. Epub 2012 Aug 8. Am J Physiol Renal Physiol. 2012. PMID: 22874761 Free article.

10

Acute inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel by thyroid hormones involves multiple mechanisms.

Cai Z, Li H, Chen JH, Sheppard DN. Cai Z, et al. Among authors: sheppard dn. Am J Physiol Cell Physiol. 2013 Oct 15;305(8):C817-28. doi: 10.1152/ajpcell.00052.2013. Epub 2013 Jun 19. Am J Physiol Cell Physiol. 2013. PMID: 23784545 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters